Siemens Healthineers Profit Rises on Revenue Growth
By Adria Calatayud
Siemens Healthineers reported a rise in net profit for the first quarter of fiscal 2024, helped by higher sales driven by growth in its Varian radiation-oncology business.
Net profit for the quarter to December amounted to 431 million euros ($466.3 million) compared with EUR421 million in the same period a year before, the German healthcare-equipment company said.
Revenue rose to EUR5.18 billion from EUR5.08 billion. Revenue was up 5.7% on a comparable basis, with rises in Varian and the company's imaging and advanced-therapies segments offsetting a drop in diagnostics sales.
Adjusted earnings before interest and taxes grew to EUR742 million from EUR685 million, while the margin expanded to 14.3% from 13.5%.
Analysts had expected Siemens Healthineers to report a net profit of EUR395 million, adjusted EBIT of EUR742 million and revenue of EUR5.11 billion, according to consensus estimates provided by the company.
The company reiterated its guidance for the year ending in September.
Write to Adria Calatayud at adria.calatayud@wsj.com
(END) Dow Jones Newswires
February 01, 2024 01:16 ET (06:16 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks